ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 617

$894K Total Retail Price of All Prescriptions

Rank: 9 out of 617

618 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 15,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 786 671 1 1
SIMVASTATIN 624 565 2 2
AMLODIPINE BESYLATE 624 607 2 6
OMEPRAZOLE 586 509 4 3
METFORMIN HCL 553 505 5 9
WARFARIN SODIUM 531 469 6 7
METOPROLOL SUCCINATE 498 460 7 12
LISINOPRIL 460 416 8 5
METOPROLOL TARTRATE 418 408 9 11
HYDROCHLOROTHIAZIDE 378 351 10 13
LOSARTAN POTASSIUM 356 323 11 22
HYDROCODONE-ACETAMINOPHEN 346 300 S3 12 8
FUROSEMIDE 334 314 13 4
PRAVASTATIN SODIUM 302 260 14 21
SERTRALINE HCL 283 254 15 20
POTASSIUM CHLORIDE 269 238 16 10
ALLOPURINOL 268 240 17 27
GABAPENTIN 222 183 18 16
MELOXICAM 220 198 19 24
CRESTOR 212 181 20 28
DIOVAN 205 177 21 41
ATORVASTATIN CALCIUM 204 197 22 14
GLIMEPIRIDE 191 179 23 33
ATENOLOL 173 156 24 17
CARVEDILOL 170 166 25 19
TRAMADOL HCL 167 104 26 15
PANTOPRAZOLE SODIUM 160 148 27 37
DONEPEZIL HCL 160 160 27 30
ZOLPIDEM TARTRATE 149 132 29 23
COUMADIN 142 142 30 167
TAMSULOSIN HCL 137 137 31 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 115 32 29
CITALOPRAM HBR 128 116 33 18
BYSTOLIC 114 106 34 64
CIPROFLOXACIN HCL 105 97 35 60
SYNTHROID 103 97 36 59
LOSARTAN-HYDROCHLOROTHIAZIDE 99 99 37 46
ALENDRONATE SODIUM 97 96 38 25
POLYETHYLENE GLYCOL 3350 96 53 39 32
NEXIUM 93 92 40 43
DICLOFENAC SODIUM 92 53 41 98
RISPERIDONE 90 90 42 71
CLOPIDOGREL 90 74 42 53
LEVEMIR FLEXPEN 89 86 44 212
ISOSORBIDE MONONITRATE ER 89 85 44 52
TRAZODONE HCL 88 74 46 51
LANTUS 88 82 46 39
MIRTAZAPINE 87 87 48 50
CYMBALTA 85 40 49 49
NAMENDA 84 84 50 35
DIGOXIN 83 83 51 48
ADVAIR DISKUS 82 75 52 38
DIOVAN HCT 81 81 53 97
BACLOFEN 78 30 54 146
CLONIDINE HCL 76 64 55 55
SPIRIVA 75 74 56 61
TRILIPIX 74 41 57 171
QUETIAPINE FUMARATE 73 45 58 78
PREDNISONE 72 61 59 31
FAMOTIDINE 70 53 60 54
VESICARE 69 58 61 95
PEN NEEDLE 65 60 62 174
FENTANYL 64 51 S2 63 45
SPIRONOLACTONE 62 50 64 42
TRIAMTERENE-HCTZ 62 48 64 47
FLUTICASONE PROPIONATE 62 41 64 36
PROPRANOLOL HCL 62 55 64 109
INSULIN SYRINGE 62 58 64 148
PAROXETINE HCL 61 37 69 62
LANTUS SOLOSTAR 60 59 70 115
OXYBUTYNIN CHLORIDE ER 59 48 71 114
CEPHALEXIN 59 53 71 68
ESCITALOPRAM OXALATE 58 58 73 65
NOVOLOG 58 50 73 137
TRICOR 58 55 73 83
AGGRENOX 56 56 76 155
GLYBURIDE 56 54 R 76 84
HUMALOG MIX 75-25 54 54 78 254
NOVOLOG FLEXPEN 54 46 78 203
NIASPAN 53 53 80 103
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 80 80
AVODART 52 52 82 144
DILTIAZEM ER 52 52 82 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.